/term/net-change-in-cash/LSE:BIOG Biotech Growth Trust (The) (LSE:BIOG) Net Change in Cash
GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Biotech Growth Trust (The) PLC (LSE:BIOG) » Definitions » Net Change in Cash

Biotech Growth Trust (The) (LSE:BIOG) Net Change in Cash : £-0.64 Mil (TTM As of Mar. 2024)


View and export this data going back to 1997. Start your Free Trial

What is Biotech Growth Trust (The) Net Change in Cash?

Net Change in Cash is calculated as the total of Cash Flow from Operations , Cash Flow from Investing, Cash Flow from Financing, and Effect of Exchange Rate Changes.

Biotech Growth Trust (The)'s Net Change in Cash for the six months ended in Mar. 2024 was £-1.00 Mil. Its Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 was £-0.64 Mil.

Biotech Growth Trust (The) Net Change in Cash Historical Data

The historical data trend for Biotech Growth Trust (The)'s Net Change in Cash can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Biotech Growth Trust (The) Net Change in Cash Chart

Biotech Growth Trust (The) Annual Data
Trend Mar15 Mar16 Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24
Net Change in Cash
Get a 7-Day Free Trial Premium Member Only Premium Member Only - 1.50 -1.50 2.77 -0.64

Biotech Growth Trust (The) Semi-Annual Data
Sep14 Mar15 Sep15 Mar16 Sep16 Mar17 Sep17 Mar18 Sep18 Mar19 Sep19 Mar20 Sep20 Mar21 Sep21 Mar22 Sep22 Mar23 Sep23 Mar24
Net Change in Cash Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only -3.87 - 2.77 0.36 -1.00

Biotech Growth Trust (The) Net Change in Cash Calculation

Biotech Growth Trust (The)'s Net Change in Cash for the fiscal year that ended in Mar. 2024 is calculated as

Net Change in Cash= Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-4.241+22.341+-18.741+0
=-0.64

Biotech Growth Trust (The)'s Net Change in Cash for the quarter that ended in Mar. 2024

Net Change in Cash=Cash Flow from Operations+Cash Flow from Investing+Cash Flow from Financing+Effect of Exchange Rate Changes
=-2.369+-13.698+15.065+0
=-1.00

Net Change in Cash for the trailing twelve months (TTM) ended in Mar. 2024 adds up the semi-annually data reported by the company within the most recent 12 months, which was £-0.64 Mil.

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Biotech Growth Trust (The) Net Change in Cash Related Terms

Thank you for viewing the detailed overview of Biotech Growth Trust (The)'s Net Change in Cash provided by GuruFocus.com. Please click on the following links to see related term pages.

Biotech Growth Trust (The) (LSE:BIOG) Business Description

Industry
GURUFOCUS.COM » STOCK LIST » Financial Services » Asset Management » Biotech Growth Trust (The) PLC (LSE:BIOG) » Definitions » Net Change in Cash
Comparable Companies
LSE:BIPS LSE:NAVF LSE:AIE LSE:JAGI LSE:CTUK LSE:MTW LSE:SST LSE:HINT LSE:HNE LSE:BRK BLK BX KKR OSTO:INVE A TSX:BN APO BK AMP XSWX:PGHN OSTO:EQT
Traded in Other Exchanges
BIOGl:UK
Address
25 Southampton Buildings, London, GBR, WC2A 1AL
Website
https://www.biotechgt.com
Biotech Growth Trust (The) PLC is a United Kingdom-based investment trust. Its business objective is to provide its investors with capital appreciation by investing in the biotechnology industry around the world. The company portfolio comprises emerging biotechnology companies across North America, Europe, and Asia, of which North America accounts for the investment share.

Biotech Growth Trust (The) (LSE:BIOG) Headlines

No Headlines